Inogen (INGN) Depreciation & Amortization (CF) (2013 - 2026)
Inogen (INGN) posted quarterly Depreciation & Amortization (CF) of $4.9 million for Q1 2026, down 5.49% year-over-year from $5.2 million in Q1 2025, and down 2.6% quarter-over-quarter from $5.0 million in Q4 2025.
Inogen (INGN) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Depreciation & Amortization (CF) for 14 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 5.49% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $20.4 million (down 2.65% YoY), while the FY2025 annual figure was $20.7 million, down 1.64% from the prior year.
- Depreciation & Amortization (CF) declined to $4.9 million in Q1 2026 per INGN's latest filing, from $5.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $6.0 million in Q4 2022 and bottomed at $4.1 million in Q1 2023.
- Historically, Depreciation & Amortization (CF) has averaged $5.2 million across 5 years, with a median of $5.2 million in 2025.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) dropped 29.06% — and 2024, when it gained 28.85%.
- Inogen's Depreciation & Amortization (CF) stood at $6.0 million in 2022, then declined by 13.95% to $5.1 million in 2023, then fell by 1.24% to $5.1 million in 2024, then fell by 0.89% to $5.0 million in 2025, then dropped by 2.6% to $4.9 million in 2026.
- Business Quant data shows INGN's Depreciation & Amortization (CF) at $4.9 million in Q1 2026, $5.0 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Inogen | 152.26 Mn | 46.72 Mn | 43.27 Mn | 4.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.70 Mn |
| Jun 30, 2026 | 4.70 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 5.04 Mn |
| Dec 31, 2025 | 5.04 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Dec 31, 2024 | 5.08 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 5.27 Mn |
| Mar 31, 2024 | 5.27 Mn |